Search | TVST | ARVO Journals

Showing 1 – 20 of 21

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Higher protein concentrations are toxic for photoreceptors and correlate with lower functional recovery after rhegmatogenous retinal detachment

Alejandra Daruich; Emilie Picard; Jeffrey H Boatright; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3680.

ARVO Annual Meeting Abstract June 2021

Long-term oral treatment with low dose glibenclamide reduces diabetic retinopathy damage in the Goto-Kakizaki rat model

Marianne Berdugo-Polak; kimberley delaunay; Marie-Christine Naud; Lolita Radet; Emmanuelle Gelizé; Simon Perreau; Laurent Jonet; Dalen Rosa; Théo Guyon; Emilie Picard; Alejandra Daruich; Jacques Beltrand; Elsa Kermorvant-Duchemin; Michel Polak; Patricia Crisanti; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1092.

ARVO Annual Meeting Abstract July 2019

Adjuvant ursodeoxycholic acid for retinal detachment : a potential neuroprotective therapy.

Alejandra Daruich; Emilie Picard; Marta Zola; Hugues Henry; Jeffrey H Boatright; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2795.

ARVO Annual Meeting Abstract July 2019

Retina transcriptome underlie the neuroprotective actions of transferrin.

Picard Emilie; Alejandra Daruich; quentin lerouzic; Marie-Christine Naud; Laurent Jonet; Laura Kowalczuk; Jean-Antoine Pournaras; Jeffrey H. Boatright; Aurélien Thomas; Natacha Turck; Alexandre Moulin; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5720.

Articles January 2018

Proteome and Metabolome of Subretinal Fluid in Central Serous Chorioretinopathy and Rhegmatogenous Retinal Detachment: A Pilot Case Study

PDF

Laura Kowalczuk; Alexandre Matet; Marianne Dor; Nasim Bararpour; Alejandra Daruich; Ali Dirani; Francine Behar-Cohen; Aurélien Thomas; Natacha Turck
TAGS: central serous chorioretinopathy, metabolites, proteins, proteome, radiation recall dermatitis, rhegmatogenous retinal detachment, metabolomics, mass spectrometry, proteomics, medical history
Trans. Vis. Sci. Tech.. 2018; 7(1):3. https://doi.org/10.1167/tvst.7.1.3

Includes: Supplemental Content

Retina August 2017

Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma: Optical Coherence Tomography Angiography Alterations Influencing Visual Acuity

PDF

Alexandre Matet; Alejandra Daruich; Leonidas Zografos
TAGS: angiogram, intraocular melanoma, macular disorders, optical coherence tomography, protons, radiation, visual acuity, blood capillaries, fractals, eye
Invest. Ophthalmol. Vis. Sci.. 2017; 58(10):3851-3861. https://doi.org/10.1167/iovs.17-22324

ARVO Annual Meeting Abstract June 2017

Subfoveal nodule in Coats disease: towards an updated classification predicting visual prognosis

Alejandra Daruich; Alexandre Moulin; Hoai Viet Tran; Alexandre Matet; Francis L Munier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2423.

ARVO Annual Meeting Abstract June 2017

Iron role in retinal detachment and neuroprotective effects of transferrin

Emilie Picard; Alejandra Daruich; Quentin LeRouzic; Laurent Jonet; Marie-Christine Naud; Laura Kowalczuk; Aurélien Thomas; Natacha Turck; Thomas J. wolfensberger; Alexandre Moulin; Jean-Antoine Pournaras; Yves Courtois; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1593.

ARVO Annual Meeting Abstract June 2017

Risk factors for recurrences in central serous chorioretinopathy

Alexandre Matet; Alejandra Daruich; Marta Zola; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2965.

ARVO Annual Meeting Abstract June 2017

Chronic central serous chorioretinopathy treated with mineralocorticoid-receptor antagonists: long-term follow up.

Marta Zola; Alejandra Daruich; Alexandre Matet; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5931.

ARVO Annual Meeting Abstract September 2016

Extramacular fibrosis in Coats’ disease

Alejandra Daruich; Alexandre Matet; Marie-Claire Gaillard; Hoai Viet Tran; Francis L Munier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):160.

ARVO Annual Meeting Abstract September 2016

Oral mineralocorticoid-receptor antagonists: real-life experience in clinical subtypes of non-resolving central serous chorioretinopathy with chronic epitheliopathy

Alexandre Matet; Alejandra Daruich; Ali Dirani; Mathilde Gallice; Luke Nicholson; Sobha Sivaprasad; Francine Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

ARVO Annual Meeting Abstract September 2016

Evaluation of the efficacy of the nurse triage at the ophthalmic emergencies of the Jules Gonin Ophthalmic Hospital (HOJG), Lausanne, Switzerland

Aurelie Pison; Ciara Bergin; Christina Gianniou; Aurélie Martin; Alejandra Daruich; Yan Guex-Crosier; Jean-Louis Bourges; Francine Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5550.

ARVO Annual Meeting Abstract September 2016

Biological rationale for the clinical effect of aflibercept in patients with idiopathic macular telangiectasia type 1

Laura Kowalczuk; Ali Dirani; Alexandre Matet; Alejandra Daruich; Aude Ambresin; Irmela Mantel; Natacha Turck; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

Articles March 2016

Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy

PDF

Alejandra Daruich; Alexandre Matet; Ali Dirani; Mathilde Gallice; Luke Nicholson; Sobha Sivaprasad; Francine Behar-Cohen
TAGS: antagonists, central serous chorioretinopathy, mineralocorticoid receptor, recurrence, eye, spironolactone, eplerenone, persistence
Trans. Vis. Sci. Tech.. 2016; 5(2):2. https://doi.org/10.1167/tvst.5.2.2

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2015

Risk factors and choroidal changes in patients with unilateral versus bilateral chronic active CSCR

Ali Dirani; Alexandre Matet; Alejandra B Daruich; Parmis Parvin; martine elalouf; Aude Ambresin; Irmela Mantel; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3718.

ARVO Annual Meeting Abstract June 2015

Central serous chorioretinopathy: profile of subretinal fluid spontaneous resolution

Alejandra B Daruich; Alexandre Matet; Laetitia Marchionno; Ali Dirani; Irmela Mantel; Aude Ambresin; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3728.

ARVO Annual Meeting Abstract June 2015

Type 2 idiopathic macular telangiectasia (MacTel): multimodal imaging of perifoveal microcysts

Alexandre Matet; Aude Ambresin; Ali Dirani; Alejandra B Daruich; Irmela Mantel; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3850.

ARVO Annual Meeting Abstract April 2014

Tauroursodeoxycholic acid (TUDCA) protects against human sub-retinal fluid toxicity in photoreceptor-enriched chick cell cultures

Priscila Cunha; Fazila Aseem; Alejandra Daruich; Will Johnson; Preston Girardot; Micah A Chrenek; P Michael Iuvone; Francine F Behar-Cohen; Jeffrey H Boatright

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1343.

ARVO Annual Meeting Abstract April 2014

Analysis of retinal toxicity of recombinant tissue plasminogen activator

Alejandra Daruich; Marianne Berdugo; Kimberley Delaunay; Marie-Christine Naud; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4897.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Higher protein concentrations are toxic for photoreceptors and correlate with lower functional recovery after rhegmatogenous retinal detachment

Long-term oral treatment with low dose glibenclamide reduces diabetic retinopathy damage in the Goto-Kakizaki rat model

Adjuvant ursodeoxycholic acid for retinal detachment : a potential neuroprotective therapy.

Retina transcriptome underlie the neuroprotective actions of transferrin.

Proteome and Metabolome of Subretinal Fluid in Central Serous Chorioretinopathy and Rhegmatogenous Retinal Detachment: A Pilot Case Study

Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma: Optical Coherence Tomography Angiography Alterations Influencing Visual Acuity

Subfoveal nodule in Coats disease: towards an updated classification predicting visual prognosis

Iron role in retinal detachment and neuroprotective effects of transferrin

Risk factors for recurrences in central serous chorioretinopathy

Chronic central serous chorioretinopathy treated with mineralocorticoid-receptor antagonists: long-term follow up.

Extramacular fibrosis in Coats’ disease

Oral mineralocorticoid-receptor antagonists: real-life experience in clinical subtypes of non-resolving central serous chorioretinopathy with chronic epitheliopathy

Evaluation of the efficacy of the nurse triage at the ophthalmic emergencies of the Jules Gonin Ophthalmic Hospital (HOJG), Lausanne, Switzerland

Biological rationale for the clinical effect of aflibercept in patients with idiopathic macular telangiectasia type 1

Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy

Risk factors and choroidal changes in patients with unilateral versus bilateral chronic active CSCR

Central serous chorioretinopathy: profile of subretinal fluid spontaneous resolution

Type 2 idiopathic macular telangiectasia (MacTel): multimodal imaging of perifoveal microcysts

Tauroursodeoxycholic acid (TUDCA) protects against human sub-retinal fluid toxicity in photoreceptor-enriched chick cell cultures

Analysis of retinal toxicity of recombinant tissue plasminogen activator

To View More...

You must be signed into an individual account to use this feature.